Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 106 | 2023 | 1164 | 19.800 |
Why?
|
alpha-Synuclein | 51 | 2023 | 138 | 13.890 |
Why?
|
Genetic Therapy | 37 | 2023 | 89 | 9.610 |
Why?
|
Neurons | 60 | 2023 | 374 | 8.790 |
Why?
|
Huntington Disease | 20 | 2021 | 60 | 6.120 |
Why?
|
Dopaminergic Neurons | 17 | 2020 | 44 | 6.070 |
Why?
|
Substantia Nigra | 41 | 2023 | 148 | 5.810 |
Why?
|
Animals | 144 | 2023 | 4552 | 5.800 |
Why?
|
Disease Models, Animal | 51 | 2021 | 724 | 5.370 |
Why?
|
Corpus Striatum | 32 | 2020 | 111 | 5.260 |
Why?
|
Neurturin | 17 | 2023 | 24 | 4.660 |
Why?
|
Multiple System Atrophy | 11 | 2021 | 42 | 4.160 |
Why?
|
Dependovirus | 23 | 2021 | 37 | 3.800 |
Why?
|
Genetic Vectors | 26 | 2021 | 60 | 3.750 |
Why?
|
Brain | 26 | 2022 | 1689 | 3.150 |
Why?
|
Nerve Degeneration | 13 | 2021 | 55 | 3.070 |
Why?
|
Lewy Bodies | 13 | 2022 | 195 | 3.050 |
Why?
|
Dopamine | 28 | 2023 | 156 | 3.040 |
Why?
|
Neuroprotective Agents | 15 | 2020 | 59 | 3.000 |
Why?
|
Tyrosine 3-Monooxygenase | 30 | 2023 | 83 | 2.900 |
Why?
|
Parkinsonian Disorders | 14 | 2021 | 217 | 2.830 |
Why?
|
Nerve Growth Factors | 10 | 2018 | 44 | 2.800 |
Why?
|
Humans | 143 | 2023 | 29337 | 2.700 |
Why?
|
Brain Tissue Transplantation | 10 | 2017 | 25 | 2.580 |
Why?
|
Neostriatum | 8 | 2020 | 22 | 2.550 |
Why?
|
Fetal Tissue Transplantation | 11 | 2017 | 35 | 2.380 |
Why?
|
Induced Pluripotent Stem Cells | 5 | 2020 | 16 | 2.340 |
Why?
|
Rats | 36 | 2023 | 854 | 2.280 |
Why?
|
Putamen | 9 | 2020 | 23 | 2.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 6 | 2018 | 59 | 2.080 |
Why?
|
Aging | 23 | 2018 | 1593 | 2.000 |
Why?
|
Nerve Tissue Proteins | 18 | 2016 | 173 | 2.000 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 14 | 2021 | 30 | 1.950 |
Why?
|
Antiparkinson Agents | 6 | 2017 | 130 | 1.710 |
Why?
|
Immunohistochemistry | 31 | 2022 | 391 | 1.680 |
Why?
|
Macaca mulatta | 30 | 2021 | 65 | 1.680 |
Why?
|
Mesencephalon | 10 | 2017 | 44 | 1.680 |
Why?
|
Gene Transfer Techniques | 12 | 2021 | 35 | 1.570 |
Why?
|
Cell- and Tissue-Based Therapy | 6 | 2021 | 14 | 1.480 |
Why?
|
Neurodegenerative Diseases | 7 | 2019 | 117 | 1.440 |
Why?
|
Male | 79 | 2022 | 15621 | 1.420 |
Why?
|
Prodromal Symptoms | 2 | 2021 | 19 | 1.420 |
Why?
|
Oligodendroglia | 3 | 2020 | 26 | 1.420 |
Why?
|
Mice | 29 | 2022 | 1607 | 1.420 |
Why?
|
Extracorporeal Shockwave Therapy | 2 | 2019 | 3 | 1.410 |
Why?
|
Colon | 5 | 2018 | 148 | 1.380 |
Why?
|
Dyskinesia, Drug-Induced | 4 | 2020 | 54 | 1.360 |
Why?
|
MPTP Poisoning | 4 | 2016 | 16 | 1.320 |
Why?
|
Prions | 3 | 2019 | 5 | 1.290 |
Why?
|
Lewy Body Disease | 2 | 2022 | 98 | 1.290 |
Why?
|
Microglia | 8 | 2021 | 124 | 1.290 |
Why?
|
Graft Survival | 8 | 2017 | 98 | 1.270 |
Why?
|
Proto-Oncogene Proteins c-ret | 3 | 2021 | 9 | 1.250 |
Why?
|
Female | 70 | 2022 | 16197 | 1.230 |
Why?
|
Macaca fascicularis | 12 | 2021 | 26 | 1.210 |
Why?
|
Rats, Sprague-Dawley | 19 | 2020 | 451 | 1.190 |
Why?
|
Cell Transplantation | 7 | 2013 | 29 | 1.180 |
Why?
|
Stem Cell Transplantation | 7 | 2020 | 40 | 1.140 |
Why?
|
Nerve Regeneration | 6 | 2009 | 14 | 1.110 |
Why?
|
Primates | 6 | 2018 | 17 | 1.060 |
Why?
|
Enteric Nervous System | 2 | 2018 | 5 | 1.060 |
Why?
|
Levodopa | 5 | 2020 | 142 | 1.030 |
Why?
|
Stem Cells | 5 | 2020 | 46 | 0.990 |
Why?
|
Aged | 35 | 2022 | 9448 | 0.950 |
Why?
|
Alzheimer Disease | 10 | 2023 | 1942 | 0.940 |
Why?
|
Axons | 3 | 2018 | 38 | 0.930 |
Why?
|
Aged, 80 and over | 21 | 2022 | 4851 | 0.910 |
Why?
|
Down-Regulation | 4 | 2014 | 112 | 0.910 |
Why?
|
Neurotoxins | 5 | 2007 | 19 | 0.870 |
Why?
|
Cell Count | 14 | 2019 | 99 | 0.870 |
Why?
|
Parkinson Disease, Secondary | 4 | 2020 | 29 | 0.840 |
Why?
|
Cisterna Magna | 1 | 2021 | 7 | 0.810 |
Why?
|
Mutation | 8 | 2021 | 383 | 0.810 |
Why?
|
Ribosomal Protein S6 | 1 | 2021 | 3 | 0.800 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 254 | 0.800 |
Why?
|
Quinolinic Acid | 8 | 2019 | 9 | 0.790 |
Why?
|
Gastrointestinal Diseases | 2 | 2018 | 43 | 0.780 |
Why?
|
Mitomycin | 1 | 2020 | 12 | 0.770 |
Why?
|
Cerebral Cortex | 9 | 2019 | 195 | 0.760 |
Why?
|
Clinical Trials as Topic | 5 | 2016 | 324 | 0.750 |
Why?
|
Reproduction | 2 | 2016 | 12 | 0.740 |
Why?
|
Middle Aged | 31 | 2020 | 9823 | 0.720 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2019 | 1 | 0.710 |
Why?
|
Homeodomain Proteins | 2 | 2019 | 55 | 0.710 |
Why?
|
Neurosciences | 2 | 2009 | 10 | 0.710 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factors | 2 | 2011 | 3 | 0.710 |
Why?
|
Mice, Transgenic | 9 | 2022 | 248 | 0.700 |
Why?
|
Estrogen Replacement Therapy | 4 | 2010 | 20 | 0.700 |
Why?
|
Immunotherapy | 1 | 2019 | 62 | 0.700 |
Why?
|
Huntingtin Protein | 8 | 2019 | 12 | 0.690 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 43 | 0.690 |
Why?
|
Estradiol | 3 | 2010 | 58 | 0.680 |
Why?
|
Motor Activity | 9 | 2020 | 369 | 0.660 |
Why?
|
Membrane Proteins | 2 | 2019 | 173 | 0.650 |
Why?
|
Gastrointestinal Motility | 1 | 2018 | 15 | 0.650 |
Why?
|
Regeneration | 1 | 2018 | 27 | 0.650 |
Why?
|
Antibodies | 2 | 2021 | 65 | 0.640 |
Why?
|
Motor Skills Disorders | 1 | 2018 | 18 | 0.640 |
Why?
|
Transcription Factors | 4 | 2022 | 156 | 0.640 |
Why?
|
Neurogenesis | 3 | 2017 | 13 | 0.630 |
Why?
|
Central Nervous System Diseases | 1 | 2018 | 20 | 0.630 |
Why?
|
Cryopreservation | 1 | 2017 | 24 | 0.610 |
Why?
|
tau Proteins | 5 | 2023 | 202 | 0.610 |
Why?
|
Axonal Transport | 3 | 2015 | 8 | 0.600 |
Why?
|
Allografts | 2 | 2017 | 180 | 0.590 |
Why?
|
Prion Diseases | 1 | 2016 | 3 | 0.590 |
Why?
|
Cerebellum | 1 | 2016 | 57 | 0.570 |
Why?
|
Protein Aggregates | 4 | 2019 | 6 | 0.570 |
Why?
|
Transplants | 2 | 2016 | 11 | 0.570 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2016 | 22 | 0.560 |
Why?
|
Propionates | 6 | 2007 | 12 | 0.540 |
Why?
|
Recovery of Function | 5 | 2020 | 290 | 0.540 |
Why?
|
Congresses as Topic | 4 | 2017 | 33 | 0.530 |
Why?
|
Gene Expression | 6 | 2020 | 226 | 0.510 |
Why?
|
TDP-43 Proteinopathies | 1 | 2016 | 104 | 0.500 |
Why?
|
Tissue Extracts | 1 | 2014 | 13 | 0.500 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2014 | 2 | 0.500 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 4 | 2019 | 12 | 0.500 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 4 | 2020 | 13 | 0.500 |
Why?
|
Inclusion Bodies | 4 | 2021 | 14 | 0.470 |
Why?
|
Oxidopamine | 8 | 2023 | 24 | 0.460 |
Why?
|
Inflammation | 5 | 2020 | 344 | 0.460 |
Why?
|
Mice, Inbred C57BL | 12 | 2020 | 432 | 0.450 |
Why?
|
Biomarkers | 8 | 2021 | 689 | 0.450 |
Why?
|
Neurosurgery | 1 | 2013 | 49 | 0.450 |
Why?
|
Receptors, Nerve Growth Factor | 2 | 2003 | 4 | 0.450 |
Why?
|
Behavior, Animal | 11 | 2020 | 105 | 0.450 |
Why?
|
Stereotaxic Techniques | 4 | 2020 | 27 | 0.440 |
Why?
|
Promoter Regions, Genetic | 2 | 2015 | 80 | 0.440 |
Why?
|
Melanins | 4 | 2020 | 11 | 0.440 |
Why?
|
Dyneins | 1 | 2012 | 2 | 0.440 |
Why?
|
Cytoplasmic Dyneins | 1 | 2012 | 2 | 0.440 |
Why?
|
Neuroglia | 4 | 2008 | 39 | 0.440 |
Why?
|
Brain-Derived Neurotrophic Factor | 4 | 2011 | 39 | 0.440 |
Why?
|
Gene Expression Regulation | 9 | 2015 | 284 | 0.430 |
Why?
|
Movement Disorders | 1 | 2013 | 141 | 0.420 |
Why?
|
Protein Folding | 3 | 2018 | 18 | 0.420 |
Why?
|
Cell Differentiation | 7 | 2020 | 146 | 0.410 |
Why?
|
Disease Progression | 6 | 2019 | 787 | 0.400 |
Why?
|
Dentate Gyrus | 2 | 2010 | 8 | 0.390 |
Why?
|
Myogenic Regulatory Factors | 1 | 2010 | 2 | 0.390 |
Why?
|
MADS Domain Proteins | 1 | 2010 | 2 | 0.390 |
Why?
|
Nitro Compounds | 6 | 2007 | 9 | 0.380 |
Why?
|
Case-Control Studies | 6 | 2020 | 638 | 0.380 |
Why?
|
Prosencephalon | 3 | 2005 | 8 | 0.380 |
Why?
|
Progesterone | 1 | 2010 | 26 | 0.380 |
Why?
|
Treatment Outcome | 12 | 2020 | 3478 | 0.380 |
Why?
|
Protein Aggregation, Pathological | 3 | 2019 | 5 | 0.370 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2006 | 10 | 0.370 |
Why?
|
Genetic Techniques | 1 | 2009 | 1 | 0.360 |
Why?
|
Animal Rights | 1 | 2009 | 1 | 0.360 |
Why?
|
Transplantation | 1 | 2009 | 5 | 0.360 |
Why?
|
Animal Experimentation | 1 | 2009 | 2 | 0.360 |
Why?
|
Fetus | 1 | 2010 | 56 | 0.360 |
Why?
|
Oligopeptides | 2 | 2006 | 30 | 0.360 |
Why?
|
Capsid | 1 | 2009 | 10 | 0.360 |
Why?
|
Deep Brain Stimulation | 4 | 2018 | 74 | 0.360 |
Why?
|
Terrorism | 1 | 2009 | 13 | 0.360 |
Why?
|
Basal Ganglia | 1 | 2009 | 29 | 0.360 |
Why?
|
Hydrogels | 1 | 2009 | 9 | 0.360 |
Why?
|
Transplantation, Heterologous | 3 | 2014 | 20 | 0.360 |
Why?
|
Cathepsin D | 1 | 2009 | 2 | 0.360 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2009 | 2 | 0.360 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 6 | 2008 | 17 | 0.360 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 15 | 0.350 |
Why?
|
Haplorhini | 5 | 2020 | 12 | 0.350 |
Why?
|
History, 20th Century | 4 | 2017 | 84 | 0.350 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 65 | 0.350 |
Why?
|
Green Fluorescent Proteins | 5 | 2017 | 34 | 0.350 |
Why?
|
Neuronal Plasticity | 1 | 2009 | 43 | 0.350 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 2009 | 31 | 0.340 |
Why?
|
Neurofibrillary Tangles | 3 | 2023 | 181 | 0.340 |
Why?
|
Central Nervous System | 3 | 2021 | 57 | 0.340 |
Why?
|
Astrocytes | 5 | 2017 | 122 | 0.340 |
Why?
|
Biomedical Research | 1 | 2009 | 81 | 0.330 |
Why?
|
Receptor, Nerve Growth Factor | 3 | 2003 | 6 | 0.330 |
Why?
|
Rats, Inbred F344 | 7 | 2020 | 48 | 0.320 |
Why?
|
Amyloid beta-Peptides | 3 | 2023 | 294 | 0.320 |
Why?
|
Societies, Scientific | 1 | 2008 | 12 | 0.320 |
Why?
|
Cholinergic Fibers | 2 | 2005 | 6 | 0.320 |
Why?
|
Adrenal Medulla | 1 | 2007 | 31 | 0.310 |
Why?
|
Autopsy | 6 | 2018 | 335 | 0.310 |
Why?
|
Time Factors | 8 | 2013 | 1616 | 0.300 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 195 | 0.300 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 18 | 0.300 |
Why?
|
Supranuclear Palsy, Progressive | 2 | 2007 | 44 | 0.290 |
Why?
|
Tissue Distribution | 3 | 2021 | 42 | 0.290 |
Why?
|
Oxidative Stress | 3 | 2011 | 124 | 0.290 |
Why?
|
Choroid Plexus | 1 | 2006 | 7 | 0.290 |
Why?
|
Nuclear Proteins | 6 | 2014 | 88 | 0.290 |
Why?
|
Cell Death | 4 | 2007 | 61 | 0.280 |
Why?
|
Functional Laterality | 5 | 2010 | 91 | 0.280 |
Why?
|
Chemokine CCL5 | 2 | 2016 | 17 | 0.270 |
Why?
|
Models, Animal | 3 | 2021 | 126 | 0.270 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 75 | 0.270 |
Why?
|
History, 21st Century | 3 | 2017 | 36 | 0.270 |
Why?
|
Transduction, Genetic | 3 | 2021 | 18 | 0.260 |
Why?
|
Cell Survival | 6 | 2011 | 169 | 0.250 |
Why?
|
Rats, Inbred Lew | 4 | 2020 | 11 | 0.250 |
Why?
|
Basal Nucleus of Meynert | 2 | 2014 | 6 | 0.250 |
Why?
|
Peptides | 3 | 2015 | 95 | 0.240 |
Why?
|
RNA Interference | 2 | 2015 | 33 | 0.240 |
Why?
|
Cell Proliferation | 2 | 2020 | 201 | 0.240 |
Why?
|
Rotenone | 2 | 2018 | 10 | 0.240 |
Why?
|
Hippocampus | 5 | 2013 | 274 | 0.240 |
Why?
|
Adult | 12 | 2018 | 8601 | 0.240 |
Why?
|
Hypokinesia | 1 | 2023 | 27 | 0.240 |
Why?
|
Fluorescent Antibody Technique | 4 | 2021 | 78 | 0.230 |
Why?
|
Endopeptidase K | 2 | 2017 | 5 | 0.230 |
Why?
|
Cell Line | 4 | 2019 | 298 | 0.230 |
Why?
|
Ciliary Neurotrophic Factor | 3 | 2011 | 7 | 0.230 |
Why?
|
Positron-Emission Tomography | 4 | 2014 | 88 | 0.230 |
Why?
|
Sympatholytics | 4 | 2011 | 14 | 0.220 |
Why?
|
Brain Injuries | 1 | 2003 | 47 | 0.220 |
Why?
|
Tauopathies | 1 | 2022 | 17 | 0.220 |
Why?
|
Densitometry | 2 | 2021 | 10 | 0.220 |
Why?
|
Frontotemporal Dementia | 1 | 2022 | 14 | 0.220 |
Why?
|
Animals, Genetically Modified | 2 | 2021 | 17 | 0.220 |
Why?
|
beta-Globins | 1 | 2022 | 4 | 0.210 |
Why?
|
Acetylcholine | 1 | 2002 | 12 | 0.210 |
Why?
|
Signal Transduction | 3 | 2021 | 482 | 0.210 |
Why?
|
Recombinant Proteins | 2 | 2019 | 251 | 0.210 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 74 | 0.210 |
Why?
|
Rats, Transgenic | 2 | 2012 | 21 | 0.210 |
Why?
|
Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.200 |
Why?
|
Caudate Nucleus | 2 | 2016 | 18 | 0.200 |
Why?
|
Coloring Agents | 1 | 2021 | 13 | 0.200 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 37 | 0.200 |
Why?
|
Autophagy | 2 | 2022 | 30 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 1 | 2020 | 11 | 0.190 |
Why?
|
Microscopy, Confocal | 3 | 2015 | 116 | 0.190 |
Why?
|
Ovariectomy | 4 | 2010 | 26 | 0.190 |
Why?
|
Nerve Growth Factor | 2 | 2014 | 31 | 0.190 |
Why?
|
Radiopharmaceuticals | 2 | 2012 | 48 | 0.190 |
Why?
|
Severity of Illness Index | 5 | 2015 | 1113 | 0.190 |
Why?
|
Microinjections | 1 | 2019 | 6 | 0.180 |
Why?
|
Adenoviridae | 2 | 2011 | 20 | 0.180 |
Why?
|
Treatment Failure | 1 | 2020 | 159 | 0.180 |
Why?
|
Ubiquitin | 3 | 2009 | 24 | 0.180 |
Why?
|
NF-kappa B | 2 | 2012 | 107 | 0.180 |
Why?
|
Biopolymers | 1 | 2019 | 5 | 0.180 |
Why?
|
Interneurons | 1 | 2019 | 5 | 0.180 |
Why?
|
Protein Transport | 1 | 2019 | 38 | 0.180 |
Why?
|
Macrophage Activation | 1 | 2019 | 13 | 0.180 |
Why?
|
Gene-Environment Interaction | 1 | 2019 | 18 | 0.180 |
Why?
|
Organ Specificity | 1 | 2019 | 47 | 0.180 |
Why?
|
Models, Neurological | 1 | 2019 | 30 | 0.180 |
Why?
|
Chemokine CCL11 | 2 | 2016 | 8 | 0.180 |
Why?
|
Amyloid | 1 | 2019 | 53 | 0.170 |
Why?
|
Nanostructures | 1 | 2019 | 12 | 0.170 |
Why?
|
GABAergic Neurons | 1 | 2019 | 6 | 0.170 |
Why?
|
Gastrointestinal Microbiome | 2 | 2018 | 180 | 0.170 |
Why?
|
T-Lymphocytes | 1 | 2020 | 211 | 0.170 |
Why?
|
Dyskinesias | 3 | 2009 | 35 | 0.170 |
Why?
|
Mitochondria | 2 | 2016 | 78 | 0.170 |
Why?
|
Tissue Fixation | 1 | 2018 | 10 | 0.160 |
Why?
|
Psychosine | 1 | 2018 | 1 | 0.160 |
Why?
|
Galactosylceramidase | 1 | 2018 | 2 | 0.160 |
Why?
|
Formaldehyde | 1 | 2018 | 14 | 0.160 |
Why?
|
Age Factors | 6 | 2009 | 843 | 0.160 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2011 | 24 | 0.160 |
Why?
|
Cell Engineering | 1 | 2018 | 1 | 0.160 |
Why?
|
Cognition Disorders | 3 | 2019 | 1011 | 0.160 |
Why?
|
Drug Administration Schedule | 3 | 2010 | 223 | 0.160 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 161 | 0.160 |
Why?
|
Microfilament Proteins | 3 | 2015 | 22 | 0.150 |
Why?
|
Dihydroxyphenylalanine | 2 | 2010 | 7 | 0.150 |
Why?
|
Lentivirus | 3 | 2009 | 11 | 0.150 |
Why?
|
HEK293 Cells | 1 | 2017 | 70 | 0.150 |
Why?
|
Choline O-Acetyltransferase | 3 | 2006 | 14 | 0.150 |
Why?
|
Pyruvic Acid | 1 | 2016 | 4 | 0.150 |
Why?
|
Cytoprotection | 2 | 2007 | 8 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2016 | 170 | 0.150 |
Why?
|
Mice, Knockout | 3 | 2018 | 303 | 0.150 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2016 | 2 | 0.150 |
Why?
|
Calbindins | 1 | 2016 | 3 | 0.150 |
Why?
|
Cells, Cultured | 4 | 2018 | 676 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 1221 | 0.150 |
Why?
|
Permeability | 2 | 2013 | 134 | 0.140 |
Why?
|
Pyridines | 2 | 2016 | 42 | 0.140 |
Why?
|
Analysis of Variance | 5 | 2010 | 321 | 0.140 |
Why?
|
Ataxin-1 | 1 | 2015 | 1 | 0.140 |
Why?
|
Cerebellar Nuclei | 1 | 2015 | 2 | 0.140 |
Why?
|
Spinocerebellar Ataxias | 1 | 2015 | 2 | 0.140 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 55 | 0.140 |
Why?
|
Adrenergic Uptake Inhibitors | 2 | 2012 | 8 | 0.130 |
Why?
|
Tyrosine | 2 | 2011 | 23 | 0.130 |
Why?
|
DNA Methylation | 1 | 2015 | 124 | 0.130 |
Why?
|
Heterografts | 1 | 2014 | 14 | 0.120 |
Why?
|
Immune Tolerance | 1 | 2014 | 22 | 0.120 |
Why?
|
Neural Stem Cells | 1 | 2014 | 14 | 0.120 |
Why?
|
Dendrites | 2 | 2004 | 15 | 0.120 |
Why?
|
Vagus Nerve | 1 | 2013 | 14 | 0.120 |
Why?
|
Polysaccharides | 1 | 2013 | 15 | 0.120 |
Why?
|
Chromatography, Gas | 1 | 2013 | 12 | 0.120 |
Why?
|
Gastrointestinal Agents | 1 | 2013 | 12 | 0.120 |
Why?
|
Pregnancy | 3 | 2011 | 403 | 0.120 |
Why?
|
Response Elements | 1 | 2013 | 13 | 0.120 |
Why?
|
Graft Rejection | 1 | 2014 | 76 | 0.120 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 27 | 0.120 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 34 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2009 | 28 | 0.120 |
Why?
|
Receptor, Adenosine A2A | 1 | 2013 | 3 | 0.110 |
Why?
|
Swine | 2 | 2019 | 80 | 0.110 |
Why?
|
Protein Engineering | 1 | 2013 | 7 | 0.110 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2013 | 15 | 0.110 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2012 | 2 | 0.110 |
Why?
|
Transgenes | 2 | 2013 | 13 | 0.110 |
Why?
|
Morpholines | 1 | 2012 | 14 | 0.110 |
Why?
|
Linear Models | 1 | 2013 | 254 | 0.110 |
Why?
|
Carrier Proteins | 3 | 2011 | 97 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 30 | 0.110 |
Why?
|
Neurobiology | 1 | 2012 | 6 | 0.110 |
Why?
|
PPAR alpha | 1 | 2013 | 30 | 0.110 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 16 | 0.110 |
Why?
|
Neurites | 1 | 2012 | 12 | 0.110 |
Why?
|
Substance P | 1 | 2012 | 18 | 0.110 |
Why?
|
Pyrazoles | 1 | 2013 | 44 | 0.110 |
Why?
|
Calcium Channels, L-Type | 1 | 2012 | 58 | 0.110 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2011 | 1 | 0.100 |
Why?
|
Adrenergic Neurons | 1 | 2011 | 1 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 11 | 0.100 |
Why?
|
Endotoxins | 1 | 2011 | 24 | 0.100 |
Why?
|
Neurotoxicity Syndromes | 1 | 2011 | 4 | 0.100 |
Why?
|
Neuropeptides | 2 | 2008 | 29 | 0.100 |
Why?
|
Neural Pathways | 2 | 2015 | 83 | 0.100 |
Why?
|
Biopsy | 3 | 2017 | 234 | 0.100 |
Why?
|
Exploratory Behavior | 2 | 2019 | 18 | 0.100 |
Why?
|
Synaptic Transmission | 2 | 2020 | 46 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 2 | 2008 | 21 | 0.100 |
Why?
|
Injections | 2 | 2019 | 56 | 0.100 |
Why?
|
Psychomotor Performance | 2 | 2009 | 216 | 0.100 |
Why?
|
Phenotype | 2 | 2002 | 355 | 0.100 |
Why?
|
Intestines | 1 | 2011 | 107 | 0.100 |
Why?
|
MEF2 Transcription Factors | 1 | 2010 | 3 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2010 | 9 | 0.100 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2010 | 17 | 0.100 |
Why?
|
Blood Vessels | 1 | 2010 | 16 | 0.100 |
Why?
|
Enzyme Therapy | 1 | 2010 | 1 | 0.090 |
Why?
|
Isotope Labeling | 1 | 2010 | 4 | 0.090 |
Why?
|
Animals, Newborn | 4 | 2014 | 55 | 0.090 |
Why?
|
Enzymes | 1 | 2010 | 5 | 0.090 |
Why?
|
Fluorine Radioisotopes | 1 | 2010 | 8 | 0.090 |
Why?
|
Cytokines | 2 | 2015 | 347 | 0.090 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 25 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2007 | 39 | 0.090 |
Why?
|
Glutamic Acid | 1 | 2010 | 32 | 0.090 |
Why?
|
Plasmids | 1 | 2009 | 44 | 0.090 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2009 | 12 | 0.090 |
Why?
|
Presynaptic Terminals | 2 | 2010 | 16 | 0.090 |
Why?
|
Rotarod Performance Test | 1 | 2008 | 8 | 0.090 |
Why?
|
Vesicular Monoamine Transport Proteins | 1 | 2008 | 4 | 0.090 |
Why?
|
HIV-1 | 1 | 2012 | 438 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 32 | 0.090 |
Why?
|
Reference Values | 2 | 2007 | 227 | 0.090 |
Why?
|
Double-Blind Method | 4 | 2015 | 503 | 0.090 |
Why?
|
Environment | 1 | 2009 | 46 | 0.090 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2008 | 49 | 0.080 |
Why?
|
Random Allocation | 1 | 2008 | 146 | 0.080 |
Why?
|
Adolescent | 2 | 2006 | 2279 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2013 | 108 | 0.080 |
Why?
|
Anterior Thalamic Nuclei | 1 | 2008 | 4 | 0.080 |
Why?
|
RNA, Messenger | 2 | 2009 | 323 | 0.080 |
Why?
|
Gliosis | 2 | 2009 | 8 | 0.080 |
Why?
|
Hypothalamic Area, Lateral | 1 | 2007 | 2 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 130 | 0.080 |
Why?
|
Chromogranin A | 1 | 2007 | 13 | 0.080 |
Why?
|
Lipofuscin | 1 | 2007 | 1 | 0.080 |
Why?
|
Phosphorylation | 2 | 2023 | 159 | 0.080 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2007 | 2 | 0.080 |
Why?
|
Risk Factors | 2 | 2011 | 2443 | 0.080 |
Why?
|
Organisms, Genetically Modified | 1 | 2007 | 1 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 36 | 0.080 |
Why?
|
Immunoblotting | 1 | 2006 | 55 | 0.070 |
Why?
|
Maze Learning | 2 | 2019 | 16 | 0.070 |
Why?
|
Lameness, Animal | 1 | 2006 | 6 | 0.070 |
Why?
|
Epilepsy | 1 | 2008 | 104 | 0.070 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2006 | 2 | 0.070 |
Why?
|
Neuropsychological Tests | 3 | 2014 | 1251 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2009 | 1442 | 0.070 |
Why?
|
Plaque, Amyloid | 2 | 2010 | 144 | 0.070 |
Why?
|
Locomotion | 1 | 2006 | 24 | 0.070 |
Why?
|
Receptors, GABA-A | 1 | 2006 | 3 | 0.070 |
Why?
|
Fungicides, Industrial | 1 | 2006 | 1 | 0.070 |
Why?
|
Maneb | 1 | 2006 | 1 | 0.070 |
Why?
|
Paraquat | 1 | 2006 | 1 | 0.070 |
Why?
|
Herbicides | 1 | 2006 | 3 | 0.070 |
Why?
|
Pesticides | 1 | 2006 | 3 | 0.070 |
Why?
|
Matched-Pair Analysis | 1 | 2006 | 20 | 0.070 |
Why?
|
United States | 1 | 2013 | 2333 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 437 | 0.070 |
Why?
|
Bromodeoxyuridine | 1 | 2004 | 6 | 0.070 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2004 | 6 | 0.070 |
Why?
|
Obesity | 1 | 2007 | 291 | 0.060 |
Why?
|
Cytoskeleton | 1 | 2004 | 51 | 0.060 |
Why?
|
Frontal Lobe | 1 | 2004 | 81 | 0.060 |
Why?
|
3,4-Methylenedioxyamphetamine | 1 | 2003 | 1 | 0.060 |
Why?
|
Biogenic Monoamines | 1 | 2003 | 1 | 0.060 |
Why?
|
Hallucinogens | 1 | 2003 | 3 | 0.060 |
Why?
|
Gait Disorders, Neurologic | 1 | 2006 | 144 | 0.060 |
Why?
|
Estrogens | 1 | 2003 | 33 | 0.060 |
Why?
|
Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2003 | 2 | 0.060 |
Why?
|
Leukocyte Common Antigens | 1 | 2003 | 11 | 0.060 |
Why?
|
Movement | 1 | 2004 | 143 | 0.060 |
Why?
|
Luminescent Proteins | 1 | 2003 | 9 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2003 | 26 | 0.060 |
Why?
|
Nitrobenzenes | 1 | 2003 | 1 | 0.060 |
Why?
|
Isoenzymes | 1 | 2003 | 50 | 0.060 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 50 | 0.060 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 16 | 0.060 |
Why?
|
Papio | 2 | 2013 | 9 | 0.060 |
Why?
|
Immunophilins | 1 | 2002 | 2 | 0.060 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 36 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 20 | 0.060 |
Why?
|
Aspartic Acid | 1 | 2003 | 15 | 0.060 |
Why?
|
Pyrrolidines | 1 | 2002 | 21 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 42 | 0.060 |
Why?
|
Mice, SCID | 2 | 2014 | 55 | 0.060 |
Why?
|
Sulfonamides | 1 | 2003 | 54 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2003 | 52 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2003 | 146 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 10 | 0.050 |
Why?
|
Lysosomes | 1 | 2022 | 24 | 0.050 |
Why?
|
Stroke | 1 | 2006 | 293 | 0.050 |
Why?
|
Prefrontal Cortex | 1 | 2004 | 152 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2002 | 29 | 0.050 |
Why?
|
Dopamine Agents | 1 | 2002 | 40 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 85 | 0.050 |
Why?
|
Antigens, CD | 2 | 2015 | 99 | 0.050 |
Why?
|
Causality | 1 | 2002 | 53 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2021 | 22 | 0.050 |
Why?
|
Entorhinal Cortex | 1 | 2021 | 37 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2003 | 788 | 0.050 |
Why?
|
Brain Stem | 2 | 2015 | 25 | 0.050 |
Why?
|
Genotype | 1 | 2002 | 405 | 0.050 |
Why?
|
Rats, Nude | 1 | 2020 | 4 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2020 | 91 | 0.050 |
Why?
|
Autografts | 1 | 2020 | 32 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2014 | 227 | 0.050 |
Why?
|
Child | 2 | 2017 | 1346 | 0.040 |
Why?
|
Synaptophysin | 2 | 2009 | 9 | 0.040 |
Why?
|
LLC-PK1 Cells | 1 | 2019 | 2 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 2019 | 13 | 0.040 |
Why?
|
Neuroblastoma | 1 | 2019 | 19 | 0.040 |
Why?
|
Exons | 1 | 2019 | 34 | 0.040 |
Why?
|
Ventral Tegmental Area | 1 | 2019 | 12 | 0.040 |
Why?
|
CD3 Complex | 1 | 2018 | 13 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 41 | 0.040 |
Why?
|
Amygdala | 1 | 2019 | 50 | 0.040 |
Why?
|
Monocytes | 1 | 2019 | 116 | 0.040 |
Why?
|
Dysbiosis | 1 | 2018 | 64 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 138 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 264 | 0.040 |
Why?
|
Eating | 2 | 2009 | 45 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 4 | 0.040 |
Why?
|
Anxiety | 1 | 2019 | 152 | 0.040 |
Why?
|
History, 19th Century | 1 | 2017 | 66 | 0.040 |
Why?
|
Submandibular Gland | 1 | 2017 | 1 | 0.040 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2017 | 15 | 0.040 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2016 | 3 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2016 | 7 | 0.040 |
Why?
|
Brain Chemistry | 2 | 2010 | 47 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2016 | 14 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2016 | 49 | 0.040 |
Why?
|
Feces | 1 | 2017 | 98 | 0.040 |
Why?
|
Antibodies, Blocking | 1 | 2016 | 7 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2016 | 15 | 0.040 |
Why?
|
Heterozygote | 1 | 2016 | 103 | 0.040 |
Why?
|
Mental Disorders | 1 | 2018 | 140 | 0.040 |
Why?
|
Skin | 1 | 2017 | 117 | 0.040 |
Why?
|
Body Weight | 2 | 2009 | 133 | 0.040 |
Why?
|
Purkinje Cells | 1 | 2015 | 2 | 0.030 |
Why?
|
Palmitic Acid | 1 | 2015 | 5 | 0.030 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 7 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2016 | 83 | 0.030 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2015 | 14 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2015 | 30 | 0.030 |
Why?
|
Thalamus | 1 | 2015 | 28 | 0.030 |
Why?
|
Oligodendrocyte Transcription Factor 2 | 1 | 2015 | 1 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 6 | 0.030 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 2 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 218 | 0.030 |
Why?
|
Animals, Outbred Strains | 1 | 2014 | 1 | 0.030 |
Why?
|
Societies, Medical | 1 | 2016 | 190 | 0.030 |
Why?
|
Up-Regulation | 1 | 2015 | 174 | 0.030 |
Why?
|
Protein Binding | 1 | 2013 | 127 | 0.030 |
Why?
|
Radioactive Tracers | 1 | 2013 | 1 | 0.030 |
Why?
|
Synapses | 1 | 2013 | 50 | 0.030 |
Why?
|
Atomoxetine Hydrochloride | 1 | 2012 | 1 | 0.030 |
Why?
|
Propylamines | 1 | 2012 | 1 | 0.030 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 5 | 0.030 |
Why?
|
Kinetics | 1 | 2012 | 225 | 0.030 |
Why?
|
Cohort Studies | 1 | 2018 | 1939 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2010 | 1830 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 193 | 0.030 |
Why?
|
Sucrose | 1 | 2011 | 17 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2011 | 14 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 246 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 40 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 27 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 150 | 0.030 |
Why?
|
Microscopy | 1 | 2011 | 12 | 0.030 |
Why?
|
Escherichia coli | 1 | 2011 | 59 | 0.030 |
Why?
|
Gene Targeting | 1 | 2011 | 10 | 0.030 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2011 | 39 | 0.030 |
Why?
|
Memory | 1 | 2013 | 318 | 0.030 |
Why?
|
Gene Dosage | 1 | 2011 | 23 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 101 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 215 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2010 | 4 | 0.020 |
Why?
|
Silver Staining | 1 | 2010 | 5 | 0.020 |
Why?
|
NADPH Dehydrogenase | 1 | 2010 | 7 | 0.020 |
Why?
|
Weight Gain | 1 | 2011 | 66 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 45 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2010 | 34 | 0.020 |
Why?
|
Weight Loss | 1 | 2011 | 99 | 0.020 |
Why?
|
Models, Biological | 1 | 2012 | 343 | 0.020 |
Why?
|
Diet | 1 | 2011 | 174 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2009 | 46 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 220 | 0.020 |
Why?
|
CD8 Antigens | 1 | 2009 | 18 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2009 | 70 | 0.020 |
Why?
|
CD4 Antigens | 1 | 2009 | 35 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 145 | 0.020 |
Why?
|
Oleanolic Acid | 1 | 2009 | 3 | 0.020 |
Why?
|
Viral Matrix Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2009 | 15 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 16 | 0.020 |
Why?
|
Calcium | 1 | 2013 | 491 | 0.020 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2008 | 9 | 0.020 |
Why?
|
NADP | 1 | 2008 | 9 | 0.020 |
Why?
|
Videotape Recording | 1 | 2009 | 43 | 0.020 |
Why?
|
Neocortex | 1 | 2009 | 34 | 0.020 |
Why?
|
Cats | 1 | 2008 | 76 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2008 | 26 | 0.020 |
Why?
|
Spinal Cord | 1 | 2009 | 103 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 679 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 521 | 0.020 |
Why?
|
Microelectrodes | 1 | 2008 | 36 | 0.020 |
Why?
|
Drinking | 1 | 2007 | 5 | 0.020 |
Why?
|
Binding Sites | 1 | 2007 | 71 | 0.020 |
Why?
|
Syndecan-3 | 1 | 2007 | 2 | 0.020 |
Why?
|
Nerve Fibers | 1 | 2007 | 14 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2007 | 7 | 0.020 |
Why?
|
Macaca | 1 | 2006 | 4 | 0.020 |
Why?
|
Protein Subunits | 1 | 2006 | 21 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2006 | 198 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2005 | 11 | 0.020 |
Why?
|
Histological Techniques | 1 | 2005 | 6 | 0.020 |
Why?
|
Fibroblasts | 1 | 2005 | 95 | 0.020 |
Why?
|
Dynamins | 1 | 2004 | 10 | 0.020 |
Why?
|
Tubulin | 1 | 2004 | 16 | 0.020 |
Why?
|
Neurofilament Proteins | 1 | 2004 | 6 | 0.020 |
Why?
|
Age of Onset | 1 | 2004 | 108 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2004 | 42 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 75 | 0.020 |
Why?
|
Pyramidal Cells | 1 | 2004 | 44 | 0.020 |
Why?
|
Estrous Cycle | 1 | 2003 | 1 | 0.020 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2003 | 7 | 0.010 |
Why?
|
Homovanillic Acid | 1 | 2003 | 9 | 0.010 |
Why?
|
Body Constitution | 1 | 2003 | 3 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 11 | 0.010 |
Why?
|
Synucleins | 1 | 2003 | 7 | 0.010 |
Why?
|
Postmenopause | 1 | 2003 | 61 | 0.010 |
Why?
|
Body Temperature | 1 | 2003 | 58 | 0.010 |
Why?
|
Nucleus Accumbens | 1 | 2003 | 25 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2003 | 6 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 25 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 30 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 29 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 55 | 0.010 |
Why?
|
Motor Skills | 1 | 2003 | 61 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2003 | 132 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 107 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2003 | 71 | 0.010 |
Why?
|
Radiography | 1 | 2003 | 678 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 495 | 0.010 |
Why?
|
Dementia | 1 | 2006 | 521 | 0.010 |
Why?
|
Cognition | 1 | 2005 | 1277 | 0.010 |
Why?
|